Showing results (5241-5250 of 25,889) with videos related to

Sort By:
Pageof 2,589
Anticancer Research|September 15, 2019
Hypoxia-induced PGC-1α Regulates Mitochondrial Function and Tumorigenesis of Colorectal Cancer CellsChul Won Yun, Jun Hee Lee, Sang Hun Lee
Anticancer Research|September 15, 2019
Effects of Colorectal Cancer Risk Factors on the Association Between Aspirin and Colorectal CancerMax E Seaton, Ulrike Peters, Karen C Johnson, et al.
Anticancer Research|September 15, 2019
Previous Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination ChemotherapyDaijiro Harada, Kenji Takata, Shunta Mori, et al.
Anticancer Research|September 15, 2019
Incorporating Bortezomib in the Management of Plasmablastic LymphomaOnyedika Umeanaeto, Joseph Gamboa, Jesus Diaz, et al.
Anticancer Research|September 15, 2019
Surgical Strategy for Rectovaginal Fistula After Colorectal Anastomosis at a High-volume Cancer Center According to Image Type and Colonoscopy FindingsKoji Komori, Takashi Kinoshita, Taihei Oshiro, et al.
Anticancer Research|September 15, 2019
Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management StrategyMasahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, et al.
Anticancer Research|September 15, 2019
A Randomized Phase III Trial on the Role of Esophagectomy in Complete Responders to Preoperative Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESOPRESSO)Sook Ryun Park, Dok Hyun Yoon, Jong Hoon Kim, et al.
Anticancer Research|September 15, 2019
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular CarcinomaAya Takahashi, Michihisa Moriguchi, Yuya Seko, et al.
Anticancer Research|September 15, 2019
Pretreatment Serum Levels of Soluble Cytokeratin Fragments (Cyfra 21-1, TPS, MonoTotal) in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell CarcinomasDavid Kalfert, Jaroslav Ludvik, Radek Kucera, et al.
Anticancer Research|September 15, 2019
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint InhibitorsKiyohiro Ando, Kazuyuki Hamada, Makoto Watanabe, et al.
Pageof 2,589